430 related articles for article (PubMed ID: 31325802)
21. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder.
Savitz J; Dantzer R; Wurfel BE; Victor TA; Ford BN; Bodurka J; Bellgowan PS; Teague TK; Drevets WC
Psychoneuroendocrinology; 2015 Feb; 52():200-11. PubMed ID: 25486577
[TBL] [Abstract][Full Text] [Related]
22. Kynurenine pathway metabolites are associated with hippocampal activity during autobiographical memory recall in patients with depression.
Young KD; Drevets WC; Dantzer R; Teague TK; Bodurka J; Savitz J
Brain Behav Immun; 2016 Aug; 56():335-42. PubMed ID: 27091600
[TBL] [Abstract][Full Text] [Related]
23. Kynurenine pathway metabolic balance influences microglia activity: Targeting kynurenine monooxygenase to dampen neuroinflammation.
Garrison AM; Parrott JM; Tuñon A; Delgado J; Redus L; O'Connor JC
Psychoneuroendocrinology; 2018 Aug; 94():1-10. PubMed ID: 29734055
[TBL] [Abstract][Full Text] [Related]
24. The role of tryptophan metabolism in postpartum depression.
Duan KM; Ma JH; Wang SY; Huang Z; Zhou Y; Yu H
Metab Brain Dis; 2018 Jun; 33(3):647-660. PubMed ID: 29307018
[TBL] [Abstract][Full Text] [Related]
25. A validated liquid chromatography-high resolution-tandem mass spectrometry method for the simultaneous quantitation of tryptophan, kynurenine, kynurenic acid, and quinolinic acid in human plasma.
Arnhard K; Pitterl F; Sperner-Unterweger B; Fuchs D; Koal T; Oberacher H
Electrophoresis; 2018 May; 39(9-10):1171-1180. PubMed ID: 29327354
[TBL] [Abstract][Full Text] [Related]
26. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
27. Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome.
Wang S; Mu L; Zhang C; Long X; Zhang Y; Li R; Zhao Y; Qiao J
Front Endocrinol (Lausanne); 2022; 13():877807. PubMed ID: 35721725
[TBL] [Abstract][Full Text] [Related]
28. Altered kynurenine pathway metabolism in patients with ankylosing spondylitis.
Eryavuz Onmaz D; Sivrikaya A; Isik K; Abusoglu S; Albayrak Gezer I; Humeyra Yerlikaya F; Abusoglu G; Unlu A; Tezcan D
Int Immunopharmacol; 2021 Oct; 99():108018. PubMed ID: 34358860
[TBL] [Abstract][Full Text] [Related]
29. Behavioral activation therapy for depression is associated with a reduction in the concentration of circulating quinolinic acid.
Savitz J; Ford BN; Yeh HW; Akeman E; Cosgrove K; Clausen AN; Martell C; Kirlic N; Santiago J; Teague TK; Irwin MR; Paulus MP; Aupperle RL
Psychol Med; 2022 Oct; 52(13):2500-2509. PubMed ID: 33234171
[TBL] [Abstract][Full Text] [Related]
30. Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats.
Martín-Hernández D; Tendilla-Beltrán H; Madrigal JLM; García-Bueno B; Leza JC; Caso JR
Mol Neurobiol; 2019 Jan; 56(1):490-501. PubMed ID: 29725904
[TBL] [Abstract][Full Text] [Related]
31. [Depression and inflammation in rheumatic diseases].
Buras A; Waszkiewicz N; Szulc A
Postepy Hig Med Dosw (Online); 2016 Mar; 70():162-8. PubMed ID: 26943313
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a single analytical method for the determination of tryptophan, and its kynurenine metabolites in rat plasma.
Möller M; Du Preez JL; Harvey BH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 898():121-9. PubMed ID: 22608808
[TBL] [Abstract][Full Text] [Related]
33. The kynurenine pathway activities in a sub-Saharan HIV/AIDS population.
Bipath P; Levay PF; Viljoen M
BMC Infect Dis; 2015 Aug; 15():346. PubMed ID: 26285873
[TBL] [Abstract][Full Text] [Related]
34. Phase-and disorder-specific differences in peripheral metabolites of the kynurenine pathway in major depression, bipolar affective disorder and schizophrenia.
Brum M; Nieberler M; Kehrwald C; Knopf K; Brunkhorst-Kanaan N; Etyemez S; Allers KA; Bittner RA; Slattery DA; McNeill RV; Reif A; Kittel-Schneider S
World J Biol Psychiatry; 2023; 24(7):564-577. PubMed ID: 36648064
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the antioxidant properties of tryptophan and its metabolites in in vitro assay.
Nayak BN; Buttar HS
J Complement Integr Med; 2016 Jun; 13(2):129-36. PubMed ID: 26641976
[TBL] [Abstract][Full Text] [Related]
36. Suicidality and Activation of the Kynurenine Pathway of Tryptophan Metabolism.
Bryleva EY; Brundin L
Curr Top Behav Neurosci; 2017; 31():269-284. PubMed ID: 27221623
[TBL] [Abstract][Full Text] [Related]
37. Acute administration of ibuprofen increases serum concentration of the neuroprotective kynurenine pathway metabolite, kynurenic acid: a pilot randomized, placebo-controlled, crossover study.
Savitz J; Ford BN; Kuplicki R; Khalsa S; Teague TK; Paulus MP
Psychopharmacology (Berl); 2022 Dec; 239(12):3919-3927. PubMed ID: 36271950
[TBL] [Abstract][Full Text] [Related]
38. Activation of the kynurenine pathway is associated with striatal volume in major depressive disorder.
Savitz J; Dantzer R; Meier TB; Wurfel BE; Victor TA; McIntosh SA; Ford BN; Morris HM; Bodurka J; Teague TK; Drevets WC
Psychoneuroendocrinology; 2015 Dec; 62():54-8. PubMed ID: 26232650
[TBL] [Abstract][Full Text] [Related]
39. A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality.
Bay-Richter C; Linderholm KR; Lim CK; Samuelsson M; Träskman-Bendz L; Guillemin GJ; Erhardt S; Brundin L
Brain Behav Immun; 2015 Jan; 43():110-7. PubMed ID: 25124710
[TBL] [Abstract][Full Text] [Related]
40. [Kynurenine and its metabolites in nervous system diseases].
Vécsei L; Schwab F
Orv Hetil; 1992 Jul; 133(29):1803-7. PubMed ID: 1386152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
